autobus coup NouvelleZélande anita sveen Éradiquer Comorama tellement de
Anita SVEEN | Oslo University Hospital, Oslo
Oppland Arbeiderblad - Anita (38) fra Toten forsker på kreft. Nå har gruppa hun leder fått åtte millioner til forskning på immunterapi
OUH - OUS-research.no
Stiftelse støtter norsk medisinsk forskning med 48 millioner - Tu.no
ANITA Sveen, Karmsund | person | gulesider.no
OUH - Institute for Cancer Research
Cognitass er fotfestet i hverdagen - Cognita
Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1 – topic of research paper in Clinical medicine. Download scholarly article PDF and read for
Vårt motto er å gjøre det umulige... - Oslo universitetssykehus | Facebook
Ny kunnskap om tarmkreft med spredning - Kreftforeningen
Anita Sveen - Matindustrien
Sammen blir det bedre
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains | Oncogene
Anita SVEEN | Oslo University Hospital, Oslo
OUH - Molecular Oncology
Dr Anita Sveen received the Young Investigator prize at Onkologisk Forum for her research accomplishments - K.G. Jebsen Colorectal Cancer Research Centre
Preclinical drug screening identifies novel stratified treatment options according to the consensus molecular subtypes of colorectal cancer - K.G. Jebsen Colorectal Cancer Research Centre
CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka open
Tumour-infiltrating CD8 + lymphocytes and colorectal cancer recurrence by tumour and nodal stage | British Journal of Cancer
Anita SVEEN | Oslo University Hospital, Oslo
kliniskeffektforskning hashtag on Twitter
Anita SVEEN | Oslo University Hospital, Oslo
PDF) Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival